Kaiser Working With Dilbert Creator After Trump Outreach

Scott Adams, creator of Dilbert, says he has metastatic prostate cancer and that Kaiser Permanente of Northern California approved him for the targeted therapy Pluvicto but has not yet scheduled the IV infusion; Adams wrote he is “declining fast.” Adams publicly asked President Donald Trump to intervene to get the treatment scheduled, and Trump replied on Truth Social, “On it!” Robert F. Kennedy Jr., White House aide Dan Scavino and other aides signaled they were tracking the case. Kaiser and its medical directors said oncology teams are working with Adams and that their nuclear medicine and oncology experts have treated more than 150 patients with Pluvicto since its 2022 approval. Pluvicto was approved by the FDA in 2022 and its indication was expanded in March for earlier use; it is not a cure but can extend life for some men with metastatic prostate cancer. Adams, a longtime Trump supporter who faced cancellations after a 2023 racist rant, has said he expected to die this year and has discussed trying unproven treatments.